Black Diamond Therapeutics, Inc.
BDTX- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001701541
No open-market purchases or sales by Black Diamond Therapeutics, Inc. insiders were filed in the last 90 days; 96 institutions reported holding it in 13F filings for Q2 2026, worth $64.9M in total; no superinvestor holds it.
13F holders, Q2 2023
Institutional positions in Black Diamond Therapeutics, Inc. as of Jun 30, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 74
- +24 vs. Q1 2023
- Shares held
- 41.4M
- +19.9M (+92.7%) vs. Q1 2023
- Total value
- $209.2M
- +$168.6M (+415.0%) vs. Q1 2023
- New holders
- 32
- 13 more added
- Sold out
- 8
- 16 more reduced
Compare with Q1 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting BDTX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 96 | $64.9M |
| Q1 2026 | 104 | $82.0M |
| Q4 2025 | 104 | $92.0M |
| Q3 2025 | 91 | $147.0M |
| Q2 2025 | 94 | $95.8M |
| Q1 2025 | 85 | $63.0M |
| Q4 2024 | 88 | $102.5M |
| Q3 2024 | 96 | $211.9M |
| Q2 2024 | 90 | $217.9M |
| Q1 2024 | 88 | $199.9M |
| Q4 2023 | 76 | $107.1M |
| Q3 2023 | 73 | $106.8M |
| Q2 2023 | 74 | $209.2M |
| Q1 2023 | 50 | $40.6M |
| Q4 2022 | 59 | $37.9M |
| Q3 2022 | 69 | $36.3M |
| Q2 2022 | 74 | $52.9M |
| Q1 2022 | 87 | $63.5M |
| Q4 2021 | 95 | $123.7M |
| Q3 2021 | 101 | $206.3M |
| Q2 2021 | 102 | $309.6M |
| Q1 2021 | 113 | $705.5M |
Institutions, Q2 2023
Shares, value and share of portfolio for each institution holding Black Diamond Therapeutics, Inc.; share changes are against Q1 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Bellevue Group AG | 8,135,839 | $41.1M | 0.59% | +2,740,000+50.8% | Added |
| NEA Management Company, LLC | 4,448,757 | $22.5M | 1.71% | +1,000,000+29.0% | Added |
| Ra Capital Management, L.P. | 3,525,754 | $17.8M | 0.34% | +935,850+36.1% | Added |
| Artal Group S.A. | 2,046,517 | $10.3M | 0.33% | +400,000+24.3% | Added |
| Boxer Capital, LLC | 2,014,858 | $10.2M | 0.47% | 00.0% | Unchanged |
| Point72 Asset Management, L.P. | 2,000,000 | $10.1M | 0.03% | +2,000,000 | New |
| Deerfield Management Company, L.P. (Series C) | 1,800,000 | $9.09M | 0.19% | +1,800,000 | New |
| RTW Investments, LP | 1,700,000 | $8.59M | 0.16% | +1,700,000 | New |
| BlackRock Inc. | 1,505,439 | $7.60M | 0.00% | +749,052+99.0% | Added |
| Vanguard Group Inc | 1,481,385 | $7.48M | 0.00% | +723,800+95.5% | Added |
| Citadel Advisors LLC | 1,215,408 | $6.14M | 0.01% | +657,637+117.9% | Added |
| JPMorgan Chase & Co | 1,080,059 | $5.45M | 0.00% | +1,079,507+195,562.9% | Added |
| Ally Bridge Group (NY) LLC | 800,000 | $4.04M | 4.89% | +800,000 | New |
| Kennedy Capital Management, Inc. | 751,403 | $3.79M | 0.09% | +751,403 | New |
| CVI Holdings, LLC | 750,000 | $3.79M | 4.01% | +750,000 | New |
| CHI Advisors LLC | 750,000 | $3.79M | 1.15% | +750,000 | New |
| Driehaus Capital Management LLC | 696,969 | $3.52M | 0.04% | +696,969 | New |
| Rock Springs Capital Management LP | 563,233 | $2.84M | 0.07% | +563,233 | New |
| Ikarian Capital, LLC | 545,103 | $2.75M | 0.97% | +545,103 | New |
| Candriam Luxembourg S.C.A. | 500,009 | $2.53M | 0.02% | +500,009 | New |
| Parkman Healthcare Partners LLC | 500,000 | $2.52M | 0.44% | +500,000 | New |
| Verition Fund Management LLC | 450,691 | $2.28M | 0.04% | +106,384+30.9% | Added |
| Soleus Capital Management, L.P. | 435,000 | $2.20M | 0.24% | +435,000 | New |
| Eversept Partners, LP | 427,317 | $2.16M | 0.23% | +427,317 | New |
| VR Adviser, LLC | 353,629 | $1.79M | 0.29% | +353,629 | New |
| Millennium Management LLC | 352,679 | $1.78M | 0.00% | −423,915−54.6% | Reduced |
| Opaleye Management Inc. | 275,000 | $1.39M | 0.33% | +275,000 | New |
| Geode Capital Management, LLC | 271,207 | $1.37M | 0.00% | +779+0.3% | Added |
| Renaissance Technologies LLC | 220,700 | $1.11M | 0.00% | +3,200+1.5% | Added |
| EAM Investors, LLC | 207,428 | $1.05M | 0.19% | +207,428 | New |
| Newtyn Management, LLC | 200,000 | $1.01M | 0.24% | −106,609−34.8% | Reduced |
| Maven Securities LTD | 187,513 | $946.9K | 0.14% | +187,513 | New |
| Monashee Investment Management LLC | 170,000 | $858.5K | 0.20% | +170,000 | New |
| Tekla Capital Management LLC | 131,990 | $666.5K | 0.03% | 00.0% | Unchanged |
| Barclays PLC | 124,351 | $628.0K | 0.00% | +105,000+542.6% | Added |
| Boothbay Fund Management, LLC | 109,293 | $551.9K | 0.02% | +109,293 | New |
| Ergoteles LLC | 100,000 | $505.0K | 0.02% | +100,000 | New |
| State Street Corp | 76,384 | $385.7K | 0.00% | 00.0% | Unchanged |
| Bridgeway Capital Management, LLC | 75,000 | $378.8K | 0.01% | 00.0% | Unchanged |
| Acadian Asset Management LLC | 53,365 | $268.0K | 0.00% | 00.0% | Unchanged |
| Susquehanna International Group, LLP | 51,486 | $260.0K | 0.00% | −56,247−52.2% | Reduced |
| Moore Capital Management, LP | 50,000 | $252.5K | 0.01% | +50,000 | New |
| Northern Trust Corp | 37,891 | $191.3K | 0.00% | −92−0.2% | Reduced |
| Quantamental Technologies LLC | 25,377 | $128.2K | 0.05% | +25,377 | New |
| HSBC Holdings PLC | 24,156 | $119.6K | 0.00% | 00.0% | Unchanged |
| Cubist Systematic Strategies, LLC | 23,210 | $117.2K | 0.00% | +23,210 | New |
| Qube Research & Technologies Ltd | 22,904 | $115.7K | 0.00% | +22,904 | New |
| Dimensional Fund Advisors LP | 17,087 | $86.3K | 0.00% | −8,833−34.1% | Reduced |
| Morgan Stanley | 16,269 | $82.2K | 0.00% | −11,705−41.8% | Reduced |
| AE Wealth Management LLC | 15,920 | $80.4K | 0.00% | −20,000−55.7% | Reduced |
| Beacon Capital Management, LLC | 15,615 | $78.9K | 0.02% | −20,000−56.2% | Reduced |
| Bank of Montreal | 15,000 | $76.3K | 0.00% | +15,000 | New |
| Charles Schwab Investment Management Inc | 14,484 | $73.1K | 0.00% | +14,484 | New |
| Herbst Group, LLC | 13,635 | $68.9K | 0.05% | +13,635 | New |
| Two Sigma Advisers, LP | 12,800 | $64.6K | 0.00% | −163,100−92.7% | Reduced |
| State of Wisconsin Investment Board | 12,100 | $61.1K | 0.00% | −8,400−41.0% | Reduced |
| UBS Group AG | 8,519 | $43.0K | 0.00% | +8,519 | New |
| Federated Hermes, Inc. | 5,046 | $25.5K | 0.00% | −8,139−61.7% | Reduced |
| Advisor Group Holdings, Inc. | 2,484 | $11.8K | 0.00% | −1,518−37.9% | Reduced |
| Tower Research Capital LLC (TRC) | 2,116 | $10.7K | 0.00% | −5,511−72.3% | Reduced |
| Royal Bank of Canada | 1,355 | $7.00K | 0.00% | +1,160+594.9% | Added |
| US Bancorp | 700 | $3.54K | 0.00% | 00.0% | Unchanged |
| Rhumbline Advisers | 449 | $2.27K | 0.00% | +449 | New |
| Federation des caisses Desjardins du Quebec | 280 | $1.41K | 0.00% | 00.0% | Unchanged |
| Wells Fargo & Company | 247 | $1.25K | 0.00% | −394−61.5% | Reduced |
| TSFG, LLC | 100 | $1.00K | 0.00% | 00.0% | Unchanged |
| Simplex Trading, LLC | 350 | $1.00K | 0.00% | +350 | New |
| Cutler Group LP | 300 | $1.00K | 0.00% | +300 | New |
| Beaird Harris Wealth Management, LLC | 36 | $182 | 0.00% | 00.0% | Unchanged |
| Salem Investment Counselors Inc | 35 | $177 | 0.00% | 00.0% | Unchanged |
| FMR LLC | 18 | $92 | 0.00% | −66−78.6% | Reduced |
| GWM Advisors LLC | 17 | $86 | 0.00% | 00.0% | Unchanged |
| Bank of America Corp | 12 | $60 | 0.00% | −12,777−99.9% | Reduced |
| CWM, LLC | 9 | $0 | 0.00% | 00.0% | Unchanged |
| EcoR1 Capital, LLC | 0 | $0 | 0.00% | −1,191,094−100.0% | Sold out |
| MPM Oncology Impact Management LP | 0 | $0 | 0.00% | −144,888−100.0% | Sold out |
| Two Sigma Investments, LP | 0 | $0 | 0.00% | −107,754−100.0% | Sold out |
| Goldman Sachs Group Inc | 0 | $0 | 0.00% | −36,679−100.0% | Sold out |
| Bank of New York Mellon Corp | 0 | $0 | 0.00% | −18,191−100.0% | Sold out |
| K2 Principal Fund, L.P. | 0 | $0 | 0.00% | −11,316−100.0% | Sold out |
| Cambridge Investment Research Advisors, Inc. | 0 | $0 | 0.00% | −11,231−100.0% | Sold out |
| New England Capital Financial Advisors LLC | 0 | $0 | 0.00% | −24−100.0% | Sold out |